PRKD1, protein kinase D1, 5587

N. diseases: 171; N. variants: 19
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.100 Biomarker group BEFREE NPH and associated disorders are considered as ciliopathies, as all NPHP gene products are expressed in the primary cilia, similarly to the polycystic kidney disease (PKD) proteins. 18607645 2009
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.100 AlteredExpression group BEFREE Microarray expression analysis of kidneys from 30-day-old PCK rats revealed increased expression of genes previously identified in PKD renal expression profiles, such as inflammatory response, extracellular matrix synthesis, and cell proliferation genes among others, whereas the FHH.Pkhd1 did not show activation of these common markers of disease. 22669842 2012
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.100 GeneticVariation group BEFREE Oriented cell division (OCD) and convergent extension (CE) shape developing renal tubules, and their disruption has been associated with polycystic kidney disease (PKD) genes, the majority of which encode proteins that localize to primary cilia. 29033332 2017
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.100 GeneticVariation group BEFREE ADPKD is caused by mutations in the polycystic kidney disease (PKD)1 or PKD2 gene, encoding polycystin (PC)-1 or PC-2, respectively. 15563610 2005
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.100 Biomarker group BEFREE Discoidin Domain Receptor 1 (DDR1) tyrosine kinase is upregulated in PKD kidneys but does not play a role in the pathogenesis of polycystic kidney disease. 31260458 2019
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.100 Biomarker group BEFREE The structure of a PKD domain from polycystin-1: implications for polycystic kidney disease. 9889186 1999
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.100 Biomarker group BEFREE The G protein-coupled receptor (GPCR) Proteolysis Site (GPS) of cell-adhesion GPCRs and polycystic kidney disease (PKD) proteins constitutes a highly conserved autoproteolysis sequence, but its catalytic mechanism remains unknown. 22333914 2012
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.100 GeneticVariation group BEFREE Comparisons of gene expression profiles in kidney tissues at P22 and P30 in PKD and WT mice revealed that arginine metabolism was significantly activated; 204 differentially expressed genes (DEGs), including <i>Arg1</i>, an arginine metabolism-associated gene, were identified in late-stage polycystic kidneys. 30042193 2018
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.100 GeneticVariation group BEFREE Polycystic kidney disease (PKD) proteins are trans-membrane proteins that have crucial roles in many aspects of vertebrate development and physiology, including the development of many organs as well as left-right patterning and taste. 28271061 2017
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.100 GeneticVariation group BEFREE Although extremely rare, TSC and autosomal dominant polycystic kidney disease (ADPKD) can co-exist in the same patient as a result of concurrent deletion of both polycystic kidney disease (PKD) 1 and TSC2 genes present on the chromosome 16p13.3. 25519866 2014
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.100 AlteredExpression group BEFREE To overcome this problem, we previously demonstrated that folate-conjugated rapamycin (FC-rapa) targets polycystic kidneys due to the high expression of the folate receptor (FRα) and that treatment of a nonortholgous PKD mouse model leads to inhibition of renal cyst growth. 29717938 2018
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.100 GeneticVariation group BEFREE Polycystin complexes, or TRPP-PKD complexes, made of transient receptor potential channel polycystin (TRPP) and polycystic kidney disease (PKD) proteins, play key roles in coupling extracellular stimuli with intracellular Ca<sup>2+</sup> signals. 28154010 2017
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.100 GeneticVariation group BEFREE Mutations in multiple PKD genes may explain early and severe polycystic kidney disease. 22034641 2011
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.100 Biomarker group BEFREE Parallel analysis of mRNA and microRNA microarray profiles to explore functional regulatory patterns in polycystic kidney disease: using PKD/Mhm rat model. 23326503 2013
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.100 Biomarker group BEFREE Prompted by the surprising observations that disruption of IFT genes in mice led to polycystic kidney disease (PKD) and that PKD proteins are present on the sensory cilia of Caenorhabditis elegans, researchers have made a direct connection between PKD and cilia. 15723088 2005
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.100 GeneticVariation group BEFREE Based on these in vitro and in vivo observations, we propose that TMEM67 mutations cause PKD through ERK- and JNK-dependent signalling pathways, which may provide novel insight into the therapy of polycystic kidney diseases. 23456819 2013
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.100 GeneticVariation group BEFREE Polycystic livers are found in autosomal dominant polycystic kidney disease (ADPKD), caused by polycystic kidney disease (PKD)1 and PKD2 mutations in virtually all cases, and in isolated polycystic liver disease (PCLD), where 20% of cases are caused by mutations in Protein kinase C substrate 80K-H (PRKCSH) or SEC63. 24506938 2014
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.100 Biomarker group BEFREE By this, we propose a time- and cost-efficient diagnostic strategy for comprehensive molecular genetic testing of polycystic kidney disease which is highly automatable and will be of particular value when therapeutic options for PKD emerge and genetic testing is needed for larger numbers of patients. 25646624 2015